Stocktoria
REGENXBIO Inc. RGNX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-09-17
REGENXBIO Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 8,609,338 | $100.7M |
| AQR CAPITAL MANAGEMENT LLC | 1,051,712 | $8.8M |
| TWO SIGMA INVESTMENTS, LP | 554,892 | $4.6M |
| RENAISSANCE TECHNOLOGIES LLC | 305,286 | $2.6M |
| D. E. Shaw & Co., Inc. | 286,001 | $2.4M |
| MILLENNIUM MANAGEMENT LLC | 285,174 | $2.4M |
| Point72 Asset Management, L.P. | 139,791 | $1.2M |
| CITADEL ADVISORS LLC | 37,300 | $312,574 |
Source: SEC EDGAR filings · CIK 0001590877 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.